chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recvd vax in 1985 & exp unspecified allerg rxn which resulted in hospitalization;while hospitalized it was determined that the pt had unspecified cardiac problems
Pt stated that the rash started after she got home (hours after getting the shot) which she described it was dark outside.  Pt took Benadryl and states the the rash has gotten better.  States the area is very itchy too.
1430 vaccine given. 1443 started feeling dizzy, light-headed, hot. b/p 140/90,hr-78,r-20, 02 sat 98%ra. 1450 cont hot and dizzy. HR-77,02 sat 98%ra. 1500 report cont hot and dizziness gone and starting to feel better. 1510 report dizziness gone and starting to feel tired. 1515 dizziness resolved, pt stood up no dizziness. b/p 142/82. hr-66, r-18, 02 sat 98%ra, 1520 pt went home with husband who is here with her. Instructed to f/u with MD prn
Information has been received from a physician concerning a child who was vaccinated PO with the first 2.0 ml dose of Rotateq.  The physician reported that in 2007, the patient developed Salmonella based gastroenteritis.  The patient was seen in the physician's office.  The patient was noted to have some residual loose stools, but no blood.  At the time of this report, the patient still had Salmonella in the stool, but was considered to be recovering.  Additional information has been requested.
Extreme stomach distress, vomiting, diarrhea, 103 degree fever, 2 days  early onset, unusual menstruation
you still can get Shingles after having the shot because I did!; you still can get Shingles after having the shot because I did!; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication. The patient received shingles vaccine and experienced shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Within minutes of administration of the H1N1 influenza vaccine patient complained of itching and areas of patchy linear rashes appeared on bilaterally arms.
About 4 weeks after receiving the 2nd vaccine, I performed antibody titers on the patient. There was not antibody response to his TWO Moderna vaccines.  He is presently undergoing chemotherapy for Adenocarcinoma of the Lung and this is likely the reason.  Problem:  What do I recommend from here?   A third booster?  CDC says to do nothing.   I think that's a mistake.  Please advise.  The patient had no side effect or medical problem with the vaccine - just failure to develop adequate antibodies.
Slept all day; Weepy/Crying; Sad feeling/Depressed; Anxious; Headache; Little achy; Tired; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Slept all day), CRYING (Weepy/Crying), DEPRESSED MOOD (Sad feeling/Depressed), ANXIETY (Anxious) and HEADACHE (Headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy and Spice allergy. Concomitant products included THYROID (ARMOUR THYROID) from 01-Jan-2000 to an unknown date for Thyroid disorder NOS.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (Slept all day), CRYING (Weepy/Crying), DEPRESSED MOOD (Sad feeling/Depressed), ANXIETY (Anxious), HEADACHE (Headache), MYALGIA (Little achy) and FATIGUE (Tired). At the time of the report, SOMNOLENCE (Slept all day), CRYING (Weepy/Crying) and ANXIETY (Anxious) outcome was unknown, DEPRESSED MOOD (Sad feeling/Depressed) had not resolved and HEADACHE (Headache), MYALGIA (Little achy) and FATIGUE (Tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The other thing that happened the day after the vaccine was trigger finder which was better was all bent when woke up. it went away after a few days. Now seeking therapy and Transcranial magnetic stimulation and breathwork to try to get this under control.  No treatment medications were provided.   This case was linked to MOD-2021-375416, MOD-2021-375495 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Nov-2021: follow-up was received and included  patient demographics,medical history and concomitant medication
Chills; Body ache; Tired; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the arm left on 06Apr2021 at 14:30(at the age of 48-year-old) as a single dose for COVID-19 immunisation. The patient had no known medical history. Concomitant medications included famotidine (MANUFACTURER UNKNOWN) and omeprazole (MANUFACTURER UNKNOWN) from unknown date for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the arm left on 15Mar2021 at 10:00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation and took AFRIN on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received the first dose of COVID-19 vaccine within four weeks prior to the vaccination. On 07Apr2021 at 03:00 the patient experienced chills, body ache, tired and sore arm. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the events. The clinical outcomes of the events chills, body ache, tired and sore arm were recovering.  No follow-up attempts are needed. No further information is expected.
08/07/2017 - Dr. visit - After dizziness, headache, nausea, sore neck-bumps, red swollen face. Red streaks on Left forearm, torso. Very sick for few weeks. Pain on back Left side of my neck for few week.
Patient reported 72 hours post vaccination started experiencing a severe migraine with nausea and has not gotten better since.
Pregnancy with EDC of 5/7/2021.  On 3/17/2021 infant was not moving as expected, went to hospital and emergency c-section performed due to failure of BPP score.  Score was 2.  Infant delivered @ 32 week.  Wt. was 4#4 oz.  Infant had blood in urine.  After numerous studies my baby was found to have thrombosis in the intrahepatic IVC.  Treatment has started.
Apr 10, 2021 ? Jan and I both received Covid-19 Immunization at The Event Center using Janssen (J&J) 042A21A  Apr 11, 2021 ? Awoke with slurred speech. Left side of face a little droopy.  Vision partly blocked by what I thought was droopy eyebrow.  April 12, 2021 ? Made appt to see Dr. After initial checkout and some discussion she sent me directly to ER.  Arrived and was checked in and admitted; IV installed, CT Scan, chest ray, MRI and many other tests were administered. One was X_RAY recording me as I drank barium water.  I was diagnosed as having had a Stroke by Drs as well as resident Physician.  My dosage of (Imdur) Atorvastatin was increased to 80 MG per day. Other meds remain the same.  @ Dr:  226.4#, 95% ox, 56hr, 120/72 bp hospital has complete records.
RASH ON TORSO AND ABDOMEN AREA; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported and it has been requested. No concomitant medications were reported. On 22-APR-2021, the subject experienced rash on torso and abdomen area. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from rash on torso and abdomen area. This report was non-serious.
Moderna COVID-19 Vaccine EUA: After 24 hours of taking the second dose,  I have been having side effects of: - Fatigue - Fever - chills - swelling of muscle (left arm) - Muscle aches (rest of the body) - tenderness on area
Skin itching. Warm to touch knots on wrist area bilaterally. Will go away and appear somewhere else. Has received steroid pack from LP.
Patient has tested positive after the first dose of vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of SARS-COV-2 TEST POSITIVE (Patient has tested positive after the first dose of vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Patient has tested positive after the first dose of vaccine). At the time of the report, SARS-COV-2 TEST POSITIVE (Patient has tested positive after the first dose of vaccine) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
pt recv vax 3JUL96 930AM;took nap about 245PM @ 3PM mom reports found vomit on pillow;pt was unresponsive-body limp, eyes open but staring;rapid breathing called 911;taken to hosp & adm;mom states returned to nl 830PM 3JUL96 dx poss sz;
Chest pain radiating down L arm, elevated blood pressure significantly above his normal (controlled BP), tachycardia, hand pain
This spontaneous report was received from a pharmacist refers to a currently 58 years old female patient who did not have pertinent medical history, drug reactions or allergies. On 16-MAR-2015, the patient was vaccinated with a dose of ZOSTAVAX, (strength, dose, frequency, route and anatomical location were not reported), (lot # K015312, expiration date: 17-DEC-2015). The patient was not taken concomitant medications. On an unspecified date in March 2015, the patient experienced a 3 inch raised, reddened area around the injection site, no rash was presented and due this the patient went to the pharmacy on 19-MAR-2015. It was not given treatment for the adverse event and no lab diagnostics studies were performed. Product quality complaint (PQC) was not involved. The outcome of 3 inch raised, reddened area around the injection site was reported as not recovered/not resolved. The relatedness between the event and therapy with ZOSTAVAX was not reported. Additional information has been requested.
Side effects; sore arm; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION COMPLICATION (Side effects) and PAIN IN EXTREMITY (sore arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (codeine) and Drug allergy (fentanyl).    On 28-Feb-2021 at 1:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021 at 3:30 PM, the patient experienced PAIN IN EXTREMITY (sore arm). On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects). On 02-Mar-2021, PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, VACCINATION COMPLICATION (Side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PAIN IN EXTREMITY (sore arm) to be related. No further causality assessment was provided for VACCINATION COMPLICATION (Side effects).    Concomitant product use was not provided by the reporter.  Treatment for the event included unspecified different types of medications.  Patient reported he had some questions about side effects and about taking different types of medications to deal with the side effects.   This case was linked to MOD-2021-219446 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: Non-Significant Follow-up. Primary contact information updated. On 30-Jul-2021: Follow-up received on 30-Jul-2021, contains updated medical history, updated suspect details and updated event.
Patient says he still have soreness/pain on the right arm. Patient did not seek medical treatment.
Body ache; Lethargy; Aches; Fever of; Headache; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargy), PAIN (Aches), PYREXIA (Fever of), HEADACHE (Headache) and MYALGIA (Body ache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LETHARGY (Lethargy), PAIN (Aches), PYREXIA (Fever of), HEADACHE (Headache) and MYALGIA (Body ache). At the time of the report, LETHARGY (Lethargy), PAIN (Aches), PYREXIA (Fever of), HEADACHE (Headache) and MYALGIA (Body ache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
The night after getting my vaccine I developed itchiness, confusion, dizziness and I felt hot. I had flu-like symptoms with body aches, joint pain, chills and sore throat. I went to urgent care on 9/25 and was transported to the local hospital. I felt like I was going to pass out when I was being checked into the hospital. I had a seizure during one of the test. Doctor advised that my blood pressure was high.
1 hour after injection started itching at vaccination site, cheeks became bright red and by morning had "mosquito type bumps" face, arms, legs.
fatigue; heavier breath, sometimes breath utterly short; chest tightness, heart beat sometimes faster and like pumping out, sometimes like being scared reaction
Immediate arm pain when the injection was administered, was painful to raise arm after the shot, for hours. Made effort to continue to raise the arm and engage the muscle to alleviate pain, which helped by the end of *that day*, though tenderness persisted at the injection site for the following 4 to 5 days, including feeling pain when sleeping on that arm. Also, on the day of receiving the vaccine and dealing with the initial sore arm, I experienced a surge of energy lasting into the evening, that is common to me right before I fall sick ( for example as a runner, it sometimes manifests as a PR and then soon after that I get sick). The morning after the vaccine, I woke up slightly queasy, ate breakfast,  went for a bike ride and hike, then headache & nausea appeared near lunchtime (1 pm). I pushed through the rest of the afternoon but headache/nausea worsened, and by late afternoon (maybe 5 pm) I also had developed body aches, chills (with sweats), and low-grade fever.
Telephone report received from a consumer on 2/27/01, regarding an adverse event, possibly associated with influenza vaccine. A retired veterinarian called to report that approx. 2 weeks, post vax, in late 1998, a female friend of his developed temporal arteritis. This progressed to optic neuritis, with subsequent blindness in her left eye. She was hospitalized and treated with IV steroids. She continues to take oral steroids. There has been some improvement in her vision. No other information is available.
This spontaneous report was received from a nurse practitioner regarding multiple unspecified number of patients of unknown gender and age. The nurse reported that on an unknown date the multiple unspecified patient's were vaccinated with (Oka/Merck) VARIVAX (dose, frequency, lot number, expiry date not reported) that were improperly stored and no adverse effects were reported. There was no product quality complaint involved. This is one of several reports from the same reporter. Additional information has been requested.
Flu like side effects; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75 year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), administered in arm left, administration date 23Feb2021 11:45 (Lot number: EN6200) at the age of 75 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Thyroid" (unspecified if ongoing), notes: Thyroid; "Arthritis" (unspecified if ongoing); "Cholesterol" (unspecified if ongoing); "Blood pressure" (unspecified if ongoing); "Diabetic" (unspecified if ongoing).  The patient reported her blood type is A-positive if this has any bearing. The patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication(s) included: INSULIN; LEVOTHYROXINE; LOSARTAN; METOPROLOL. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious) with onset 2021, outcome "recovered" (2021), described as "Flu like side effects". The patient underwent the following laboratory tests and procedures: blood grouping: a-positive. Additional information: flu-like side effects for full two days.   No follow-up attempts are possible. No further information is expected.
After receiving the 3rd Booster of Moderna 11/18/2021, patient started experiencing symptoms 11/19/2021 of fever (101.0), headache and chills. 11/21/2021 symptoms subsided. No noted primary visit/communications.
Information was received from an attorney regarding a case in litigation concerning a female patient of unknown age. Medical history, concurrent conditions and concomitant medications were not provided. In or about 18-MAR-2015, the patient was inoculated at a pharmacy with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 02-MAY-2016, the patient was treated at a hospital for the  onset of a severe vesicular rash,  which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX, and/or despite receiving ZOSTAVAX for long term prevention of shingles. The patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. Additional information has been requested.
Patient was fine when given injection, but called and told pharmacist that she felt pain on the injection on day 6, then on day 7, injection site swelled up and is hard and painful. Patient was counseled to put some cold compress and take ibuprofen or TYLENOL for the pain. Patient was also told to contact doctor and pharmacy the next day morning if not better and pharmacy will also contact patient in a few days to follow-up.
Moderna Covid-19 vaccine EUA 10 days after the vaccine I developed a warm, red swollen patch on my arm at the injection site that is approximately 3 1/2 "x 2 1/2" that is a bit itchy.
Information has been received from a physician concerning a 4 months old infant. On 11-JAN-2013, the patient was at the office to received the first dose of ROTATEQ single dose (Lot # and expiration date were not reported). There was no adverse effect. Additional information is not expected.
Swollen tongue began 4-6 hours after receiving rabies vaccine dose #1 and rabies immune globulin. Patient took Benadryl 100mg. Resolved after 3-4 hours. "Fever" and chills began 3 hours after receiving shot, lasted through weekend. Dose #2 of rabies vaccine on 07/18/2010, swollen tongue and chest tightness began 4-6 hours later, took Benadryl 100mg, resolved in 3-4 hours. 07/19/2010 Complained of sore throat. No other symptoms. Vaccine series was discontinued.
Initial report received from a consumer on 09 Dec 2013: A 9-months-old male patient, whose medical history included allergic to cows milk and intolerance to wheat and concomitant medications were not reported, had received a dose of PENTACEL (Lot number, expiration date and route were not reported) on leg, 06 March 2013. On 06 March 2013, after receiving vaccine the patient experienced fever over a week and would not move for 3 days, lower energy for three months, glassy eyed. The patient gets a fever every month since then. The patient lost appetite for two weeks. The patient had rash on his leg at the injection site, hot to touch which lasted a week. Corrective treatment was not reported. At the time of this report the outcome of all adverse events was not recovered. Documents held by sender: none.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 23-AUG-2012 the patient was vaccinated with ZOSTAVAX, (lot#, expiration date and route not specified), as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended but rather caused the patient to contract a persistent strain of herpes zoster. On or about 24-OCT-2016 the patient was treated by a health care provider for the onset of a severe vesicular rash accompanied by weakened immune symptoms which was diagnosed as herpes zoster or shingles. The patient has been prescribed VALTREX for management of her painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering and other damages. Additional information has been requested.
Shortness of breath; sensation of pressure in my chest/lungs along with increased resting heart rate  (126-136bpm)